gcac-20230331
12/31false00014982332023Q1257P1YP3YP3Y00014982332023-01-012023-03-310001498233us-gaap:CommonStockMember2023-01-012023-03-310001498233us-gaap:WarrantMember2023-01-012023-03-3100014982332023-05-01xbrli:shares00014982332023-03-31iso4217:USD00014982332022-12-31iso4217:USDxbrli:shares0001498233us-gaap:ProductMember2023-01-012023-03-310001498233us-gaap:ProductMember2022-01-012022-03-310001498233gcac:DevelopmentRevenueMember2023-01-012023-03-310001498233gcac:DevelopmentRevenueMember2022-01-012022-03-3100014982332022-01-012022-03-310001498233us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-12-310001498233us-gaap:AdditionalPaidInCapitalMember2022-12-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2022-12-310001498233us-gaap:RetainedEarningsMember2022-12-310001498233us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-01-012023-03-310001498233us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2023-01-012023-03-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-12-310001498233srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-12-310001498233us-gaap:RetainedEarningsMember2023-01-012023-03-310001498233us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-03-310001498233us-gaap:AdditionalPaidInCapitalMember2023-03-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2023-03-310001498233us-gaap:RetainedEarningsMember2023-03-3100014982332021-12-310001498233us-gaap:PreferredStockMember2021-12-310001498233us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-12-310001498233gcac:CommonClassFMemberus-gaap:CommonStockMember2021-12-310001498233us-gaap:AdditionalPaidInCapitalMember2021-12-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310001498233us-gaap:RetainedEarningsMember2021-12-310001498233us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-01-012022-03-310001498233gcac:CommonClassFMemberus-gaap:CommonStockMember2022-01-012022-03-310001498233us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001498233us-gaap:RetainedEarningsMember2022-01-012022-03-310001498233us-gaap:CommonClassAMembergcac:TrinityWarrantsMemberus-gaap:CommonStockMember2022-01-012022-03-310001498233us-gaap:AdditionalPaidInCapitalMembergcac:TrinityWarrantsMember2022-01-012022-03-310001498233gcac:TrinityWarrantsMember2022-01-012022-03-310001498233us-gaap:CommonClassAMembergcac:SVBWarrantsMemberus-gaap:CommonStockMember2022-01-012022-03-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2022-01-012022-03-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001498233srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-3100014982332022-03-310001498233us-gaap:PreferredStockMember2022-03-310001498233us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-03-310001498233gcac:CommonClassFMemberus-gaap:CommonStockMember2022-03-310001498233us-gaap:AdditionalPaidInCapitalMember2022-03-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2022-03-310001498233us-gaap:RetainedEarningsMember2022-03-310001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembergcac:TwoCustomersMember2023-01-012023-03-31xbrli:pure0001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembergcac:ThreeCustomersMember2022-01-012022-06-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerAMember2023-01-012023-03-310001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerAMember2022-01-012022-03-310001498233gcac:CustomerBMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310001498233gcac:CustomerBMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310001498233gcac:CustomerCMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310001498233gcac:CustomerCMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerD1Member2023-01-012023-03-310001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerD1Member2022-01-012022-03-310001498233srt:RestatementAdjustmentMember2022-03-310001498233us-gaap:CommonClassAMember2022-02-1000014982332022-02-102022-02-1000014982332022-02-1000014982332022-02-090001498233us-gaap:CommonClassAMember2022-02-090001498233us-gaap:WarrantMember2021-02-0200014982332021-02-022021-02-020001498233country:JP2023-01-012023-03-310001498233country:JP2022-01-012022-03-310001498233country:US2023-01-012023-03-310001498233country:US2022-01-012022-03-310001498233country:CN2023-01-012023-03-310001498233country:CN2022-01-012022-03-310001498233gcac:OtherMember2023-01-012023-03-310001498233gcac:OtherMember2022-01-012022-03-310001498233us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2023-03-310001498233us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2023-03-310001498233us-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMember2023-03-310001498233us-gaap:MoneyMarketFundsMember2023-03-310001498233us-gaap:FairValueInputsLevel1Member2023-03-310001498233us-gaap:FairValueInputsLevel2Member2023-03-310001498233us-gaap:FairValueInputsLevel3Member2023-03-310001498233us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2023-03-310001498233us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2023-03-310001498233us-gaap:FairValueInputsLevel3Memberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2023-03-310001498233us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2023-03-310001498233us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-03-310001498233us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310001498233us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-03-310001498233us-gaap:USTreasurySecuritiesMember2023-03-310001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-03-310001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310001498233us-gaap:FairValueInputsLevel3Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2023-03-310001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMember2023-03-310001498233us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-03-310001498233us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310001498233us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2023-03-310001498233us-gaap:CorporateDebtSecuritiesMember2023-03-310001498233us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001498233us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2022-12-310001498233us-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMember2022-12-310001498233us-gaap:MoneyMarketFundsMember2022-12-310001498233us-gaap:FairValueInputsLevel1Member2022-12-310001498233us-gaap:FairValueInputsLevel2Member2022-12-310001498233us-gaap:FairValueInputsLevel3Member2022-12-310001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001498233us-gaap:FairValueInputsLevel3Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-12-310001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-12-310001498233us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001498233us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001498233us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2022-12-310001498233us-gaap:CorporateDebtSecuritiesMember2022-12-310001498233gcac:EarnoutLiabilityMember2022-12-310001498233gcac:EarnoutLiabilityMember2023-01-012023-03-310001498233gcac:EarnoutLiabilityMember2023-03-310001498233us-gaap:MachineryAndEquipmentMember2023-03-310001498233us-gaap:MachineryAndEquipmentMember2022-12-310001498233us-gaap:VehiclesMember2023-03-310001498233us-gaap:VehiclesMember2022-12-310001498233us-gaap:LeaseholdImprovementsMember2023-03-310001498233us-gaap:LeaseholdImprovementsMember2022-12-310001498233us-gaap:ComputerEquipmentMember2023-03-310001498233us-gaap:ComputerEquipmentMember2022-12-310001498233gcac:TrinityLoanAgreementMemberus-gaap:LoansPayableMember2022-01-040001498233us-gaap:LoansPayableMembergcac:TrinityLoanAgreementMember2022-01-040001498233us-gaap:LoansPayableMemberus-gaap:PrimeRateMembergcac:TrinityLoanAgreementMember2022-01-042022-01-0400014982332022-01-042022-01-0400014982332022-01-040001498233gcac:TrinityLoanAgreementMemberus-gaap:LoansPayableMember2022-01-042022-01-040001498233us-gaap:LoansPayableMembergcac:TrinityLoanAgreementMember2022-11-072022-11-070001498233us-gaap:SecuredDebtMemberus-gaap:SecuredDebtMembergcac:KoitoMember2022-10-27iso4217:JPY0001498233us-gaap:SecuredDebtMembergcac:SecuredTermLoanAgreementMember2022-10-272022-10-27gcac:businessDay0001498233us-gaap:SecuredDebtMembergcac:KoitoMember2023-01-012023-03-310001498233gcac:KoitoMember2023-01-242023-01-2400014982332023-01-242023-01-240001498233gcac:SeriesAConvertiblePreferredStockMember2022-02-090001498233gcac:SeriesBConvertiblePreferredStockMember2022-02-090001498233gcac:SeriesB1ConvertiblePreferredStockMember2022-02-090001498233gcac:SeriesCConvertiblePreferredStockMember2022-02-090001498233us-gaap:PrivatePlacementMemberus-gaap:ConvertiblePreferredStockMember2022-10-272022-10-2700014982332022-10-2700014982332023-01-192023-01-190001498233us-gaap:PrivatePlacementMemberus-gaap:ConvertiblePreferredStockMember2023-01-192023-01-1900014982332022-10-272022-10-27gcac:vote0001498233us-gaap:CommonClassAMember2022-02-102022-02-100001498233us-gaap:PrivatePlacementMember2021-11-240001498233us-gaap:PrivatePlacementMember2021-11-242021-11-2400014982332021-11-242021-11-24gcac:salesPricegcac:salesPriceDay0001498233us-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2021-11-242021-11-240001498233us-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2022-08-092022-08-0900014982332022-08-092022-08-090001498233us-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2023-01-012023-03-310001498233us-gaap:PrivatePlacementMember2023-03-310001498233gcac:CommonClassFMember2023-01-012023-03-310001498233gcac:CommonClassFMember2022-02-0900014982332022-02-092022-02-090001498233gcac:CommonClassFMember2022-02-102022-02-100001498233gcac:A2016PlanMember2016-07-050001498233gcac:A2022StockPlanMember2022-02-100001498233gcac:A2022StockPlanMember2022-02-102022-02-100001498233gcac:A2022StockPlanMember2023-03-3100014982332022-01-012022-06-300001498233us-gaap:EmployeeStockOptionMember2023-03-310001498233us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001498233gcac:A2022StockPlanMember2023-01-012023-03-310001498233srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001498233us-gaap:RestrictedStockUnitsRSUMembersrt:MaximumMember2023-01-012023-03-310001498233us-gaap:RestrictedStockUnitsRSUMember2022-12-310001498233us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001498233us-gaap:RestrictedStockUnitsRSUMember2023-03-310001498233us-gaap:PerformanceSharesMember2023-01-012023-03-310001498233us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2023-01-012023-03-310001498233us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:PerformanceSharesMember2023-01-012023-03-31gcac:tranchegcac:tradingDay0001498233us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2023-03-310001498233us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:PerformanceSharesMember2023-03-310001498233us-gaap:CostOfSalesMember2023-01-012023-03-310001498233us-gaap:CostOfSalesMember2022-01-012022-03-310001498233us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-03-310001498233us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-03-310001498233us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-03-310001498233us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-03-310001498233us-gaap:CommonClassAMembergcac:SharePriceOneMemberus-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2023-03-310001498233us-gaap:CommonClassAMembergcac:SharePriceOneMemberus-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2023-01-012023-03-310001498233us-gaap:CommonClassAMembergcac:SharePriceTwoMemberus-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2023-03-310001498233us-gaap:CommonClassAMembergcac:SharePriceTwoMember2023-01-012023-03-310001498233us-gaap:CommonClassAMembergcac:SharePriceTwoMember2023-03-3100014982332022-02-102022-09-300001498233us-gaap:IPOMember2023-03-310001498233us-gaap:CommonClassAMemberus-gaap:IPOMember2023-03-310001498233us-gaap:CommonClassAMember2023-03-310001498233us-gaap:PrivatePlacementMembergcac:SponsorMember2023-01-012023-03-310001498233gcac:BusinessCombinationMember2023-03-310001498233us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMembergcac:A2019LoanAgreementMember2019-08-3100014982332019-08-310001498233gcac:BusinessCombinationMember2019-08-310001498233us-gaap:CommonClassAMember2022-02-092022-02-090001498233us-gaap:CommonClassAMember2022-01-042022-01-040001498233us-gaap:PrivatePlacementMemberus-gaap:ConvertiblePreferredStockMember2022-10-270001498233gcac:KoitoMember2023-01-192023-01-19gcac:designee0001498233us-gaap:CommonClassAMembergcac:LincolnParkTransactionMember2023-03-310001498233us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001498233us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001498233gcac:PreferredSharesOnAnAsConvertedBasisMember2023-01-012023-03-310001498233gcac:PreferredSharesOnAnAsConvertedBasisMember2022-01-012022-03-310001498233gcac:EarnoutSharesMember2023-01-012023-03-310001498233us-gaap:ConvertiblePreferredStockMember2023-01-012023-03-31gcac:segment

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from               to               
https://cdn.kscope.io/5a6d97f2ac58116db0ecad9821a45d8c-image_001.jpg
Cepton, Inc.
(Exact name of registrant as specified in its charter)
Delaware001-3995927-2447291
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)(I.R.S. Employer
Identification Number)
399 West Trimble Road
San Jose, California
95131
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: 408-459-7579
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.00001 per shareCPTN
The Nasdaq Stock Market LLC
Redeemable warrants, exercisable for common stock at an exercise price of $11.50 per share, subject to adjustmentCPTNW
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer¨Accelerated filer¨
Non-accelerated filerxSmaller reporting companyx
Emerging growth companyx
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
As of May 1, 2023, 156,844,093 shares of common stock, par value $0.00001, of the registrant were issued and outstanding.



Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q (the “Report”) includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical or current fact included in this Report are forward-looking statements. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target,” “designed to” or other similar expressions that predict or imply future events or trends or that are not statements of historical matters. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The Company cautions readers of this Report that these forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and many of which are beyond the Company’s control, that could cause the actual results to differ materially from the expected results. These factors include the information set forth in Part II, Item 1A, of this Report under the heading “Risk Factors”, which we encourage you to carefully read. Forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics, projections of market opportunity and market share, potential benefits and the commercial attractiveness to its customers of the Company’s products and services, the potential success of the Company’s marketing and expansion strategies, and the potential for the Company to achieve design awards. These statements are based on various assumptions, whether or not identified in this Report, and on the current expectations of the Company’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. You are therefore cautioned not to place undue reliance on such statements. Any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as required by law.
i


Cepton, Inc.
Quarterly Report on Form 10-Q
Table of Contents
Page No.
Item 1.
 
 
 
 
 
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
ii


PART I - FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
CEPTON, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(In thousands, except share data)
(unaudited)
March 31,
2023
December 31,
2022
ASSETS
Current assets:
Cash and cash equivalents$41,972 $31,953 
Short-term investments38,066 3,703 
Accounts receivable, net of allowance for credit losses of $0 and $0, respectively
1,041 1,301 
Inventories3,430 2,985 
Prepaid expenses and other current assets4,772 6,272 
Total current assets89,281 46,214 
Property and equipment, net1,521 982 
Restricted cash2,565 2,565 
Other assets11,303 555 
Total assets$104,670 $50,316 
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable$1,521 $1,979 
Operating lease liabilities, current1,613 211 
Accrued expenses and other current liabilities2,766 2,265 
Short-term debt 42,587 
Total current liabilities5,900 47,042 
Warrant liability347 440 
Earnout liability158 920 
Operating lease liabilities, non-current10,158 281 
Total liabilities16,563 48,683 
Commitments and contingencies (Note 17)
Convertible preferred stock:  
Convertible preferred stock – Par value $0.00001 per share – 5,000,000 shares authorized at March 31, 2023 and December 31, 2022; 100,000 shares issued and outstanding at March 31, 2023 (aggregate liquidation preference of $100.8 million at March 31, 2023); No shares issued and outstanding at December 31, 2022
98,891  
Stockholders’ equity (deficit):  
Common stock – Par value $0.00001 per share – 350,000,000 shares authorized at March 31, 2023 and December 31, 2022; 156,844,093 and 156,747,708 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively
2 2 
Additional paid-in capital90,344 88,056 
Accumulated other comprehensive loss(329)(366)
Accumulated deficit(100,801)(86,059)
Total stockholders’ equity (deficit)(10,784)1,633 
Total liabilities, convertible preferred stock and stockholders' equity (deficit)$104,670 $50,316 
See accompanying notes to the condensed consolidated financial statements
1


CEPTON, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In thousands, except share and per share data)
(unaudited)
Three Months Ended
March 31,
20232022
Lidar sensor and prototype revenue$1,240 $1,485 
Development revenue245  
Total revenue1,485 1,485 
Lidar sensor and prototype cost of revenue1,448 1,252 
Development cost of revenue111  
Total cost of revenue1,559 1,252 
Gross (loss) profit(74)233 
Operating expenses:
Research and development7,238 7,754 
Selling, general and administrative6,731 8,043 
Total operating expenses13,969 15,797 
Operating loss(14,043)(15,564)
Other income (expense):
Gain on change in fair value of earnout liability762 56,678 
Gain on change in fair value of warrant liability94 780 
Foreign currency transaction loss, net(750) 
Loss on extinguishment of debt(1,123) 
Other income, net19 2 
Interest income (expense), net299 (694)
(Loss) income before income taxes(14,742)41,202 
Provision for income taxes (4)
Net (loss) income$(14,742)$41,198 
Net (loss) income per share, basic$(0.09)$0.36 
Net (loss) income per share, diluted$(0.09)$0.32 
Weighted-average common shares, basic156,779,565 115,865,890 
Weighted-average common shares, diluted156,779,565 127,082,423 
Net (loss) income$(14,742)$41,198 
Other comprehensive income (loss), net of tax:  
Changes in unrealized gain (loss) on available-for-sale securities17 (11)
Foreign currency translation adjustments20 (4)
Total other comprehensive income (loss), net of tax37 (15)
Comprehensive (loss) income$(14,705)$41,183 
See accompanying notes to the condensed consolidated financial statements
2


CEPTON, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit)
(In thousands, except share and per share data)
(unaudited)


Convertible
Preferred Stock
Common
Stock
Additional
Paid-in
Capital
Accumulated Other
Comprehensive
Loss
Accumulated
Deficit
Total Stockholders’
Equity
(Deficit)
SharesAmountSharesAmount
Balance — December 31, 2022 $ 156,747,708 $2 $88,056 $(366)$(86,059)$1,633 
Issuance of convertible preferred stock, net of transaction costs100,000 98,891 — — — — — — 
Exercise of stock options and release of RSUs— — 96,385 — 8 — — 8 
Stock-based compensation expense— — — — 2,280 — — 2,280 
Unrealized gain on available-for-sale investments— — — — — 17 — 17 
Cumulative translation adjustment— — — — — 20 — 20 
Net loss— — — — — — (14,742)(14,742)
Balance — March 31, 2023100,000 $98,891 156,844,093 $2 $90,344 $(329)$(100,801)$(10,784)

Convertible
Preferred Stock
Preferred
Stock
Common
Stock
Class F
Stock
Additional
Paid-in
Capital
Accumulated Other
Comprehensive
Loss
Accumulated
Deficit
Total Stockholders’
Equity
(Deficit)
SharesAmountSharesAmountSharesAmountSharesAmount
Balance — December 31, 202121,671,491 $99,470   27,618,907 $ 8,372,143 $ $7,949 $(43)$(95,439)$(87,533)
Retroactive application of exchange ratio31,407,080 — — — 40,026,282 — 12,133,201 — — — — — 
Conversion of convertible preferred stock to common stock(53,078,571)(99,470)— — 53,078,571 1 — — 99,470 — 1 99,472 
Conversion of Class F stock to common stock— — — — 20,505,344 — (20,505,344)— — — — — 
Reverse recapitalization, net of transaction costs— — — — 11,845,943 1 — — (33,051)— — (33,050)
Exercise of Trinity warrants— — — — 237,571 — — — 547 — — 547 
Exercise of SVB warrants— — — — 146,954 — — — — — — — 
Exercise of stock options— — — — 511,890 — — — 273 — — 273 
Stock-based compensation expense— — — — — — — — 1,357 — — 1,357 
Unrealized loss on available-for-sale investments— — — — — — — — — (11)— (11)
Cumulative translation adjustment— — — — — — — — — (4)— (4)
Net income— — — — — — — — — — 41,198 41,198 
Balance — March 31, 2022 $  $ 153,971,462 $2  $ $76,545 $(58)$(54,240)$22,249 
See accompanying notes to the condensed consolidated financial statements
3


CEPTON, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(In thousands)
(unaudited)
Three Months Ended
March 31,
20232022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income$(14,742)$41,198 
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization110 68 
Stock-based compensation2,289 1,347 
Amortization of right-of-use asset382 311 
Amortization, other107 (294)
Gain on change in fair value of earnout liability(762)(56,678)
Gain on change in fair value of warrant liability(94)(780)
Foreign currency transaction loss, net750  
Loss from extinguishment of debt1,123  
Changes in operating assets and liabilities:  
Accounts receivable, net260 (566)
Inventories(453)(254)
Prepaid expenses and other current assets513 (739)
Other long-term assets181 (1,945)
Accounts payable(680)(102)
Accrued expenses and other current liabilities502 (662)
Operating lease liabilities89 (389)
Other long-term liabilities (2)
Net cash used in operating activities(10,425)(19,487)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment(556)(133)
Purchases of short-term investments(37,806)(20,238)
Proceeds from maturities of short-term investments3,700 2,773 
Net cash used in investing activities(34,662)(17,598)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible preferred stock, net of transaction costs99,884  
Repayment of Koito secured term loan(45,220) 
Proceeds from Business Combination and private offering 76,107 
Payments of Business Combination and private offering transaction costs (28,038)
Proceeds from issuance of debt and warrants, net of debt discount 9,724 
Proceeds from issuance of common stock options8 235 
Net cash provided by financing activities54,672 58,028 
Effect of exchange rate changes on cash434 (4)
Net increase in cash, cash equivalents and restricted cash10,019 20,939 
Cash, cash equivalents and restricted cash, beginning of period34,518 3,654 
Cash, cash equivalents and restricted cash, end of period$44,537 $24,593 
4


SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION  
Cash paid for interest$63 $173 
Cash paid for income taxes$ $1 
Business Combination transaction costs, accrued but not paid$ $953 
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION  
Vesting of early exercised stock options$ $38 
Right-of-use assets obtained in exchange for new operating lease liabilities$11,190 $1,448 
See accompanying notes to the condensed consolidated financial statements
5


CEPTON, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (Unaudited) (
Note 1. Description of Business and Summary of Significant Accounting Policies
Description of Business
Cepton, Inc., and its wholly owned subsidiaries, (collectively, the “Company”) formerly known as Growth Capital Acquisition Corp. (“GCAC”), was originally incorporated in Delaware on January 4, 2010, under the name PinstripesNYS, Inc. GCAC changed its name to Growth Capital Acquisition Corp. on February 14, 2020. GCAC was a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more target businesses. On February 2, 2021, the Company consummated its initial public offering (the “IPO”), following which its shares began trading on the Nasdaq National Market (“Nasdaq”). On August 4, 2021, GCAC entered into a Business Combination Agreement (as amended, the “Merger Agreement”) with Cepton Technologies, Inc. (“Legacy Cepton”) and GCAC Merger Sub Inc., a wholly owned subsidiary of GCAC (“Merger Sub”). On February 10, 2022 (the “Closing Date”), the transactions contemplated by the Merger Agreement (the “Business Combination”) were consummated. In connection with the closing of the Business Combination, GCAC changed its name to Cepton, Inc. and its shares and public warrants began trading on the Nasdaq under the symbols “CPTN” and “CPTNW”, respectively. As a result of the Business Combination, Cepton, Inc. became the owner, directly or indirectly, of all of the equity interests of Legacy Cepton and its subsidiaries.
The Company provides state-of-the-art, intelligent, lidar-based solutions for a range of markets such as automotive, smart cities, smart spaces, and smart industrial applications. The Company’s patented lidar technology enables reliable, scalable, and cost-effective solutions that deliver long range, high resolution 3D perception for smart applications. The Company is headquartered in San Jose, California, USA, with a presence in Germany, Canada, Japan, China and India.
Basis of Presentation and Principles of Consolidation
The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated financial statements include the accounts of the Company's wholly owned subsidiaries in Canada, Germany, Japan, China and the United Kingdom. All intercompany balances and transactions have been eliminated in consolidation.
The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. As of March 31, 2023, the Company had cash and cash equivalents of $42.0 million, short-term investment of $38.1 million, and an accumulated deficit of $100.8 million. During the three months ended March 31, 2023, the Company incurred an operating loss of $14.0 million and had negative cash flows from operating activities of $10.4 million. Although much of the negative cash flow resulted from expenses for research and development projects and administrative expenses to support growth of the Company, the Company expects to continue to invest in research and development and generate operating losses in the future.
The Company is subject to risks and uncertainties frequently encountered by early-stage companies including, but not limited to, the uncertainty of successfully developing its products, securing certain contracts, building its customer base, successfully executing its business and marketing strategy and hiring appropriate personnel.
To date, the Company has been funded primarily by equity financings, convertible promissory notes, and the net proceeds received through the Business Combination, PIPE Investment (as defined below), and private placements of the Legacy Cepton convertible preferred stock. Failure to generate sufficient revenues, achieve planned gross margins and operating profitability, control operating costs, or secure additional funding may require the Company to modify, delay, or abandon some of its planned future expansion or development, or to otherwise enact operating cost reductions available to management, which could have a material adverse effect on the Company’s business, operating results, financial condition, and ability to achieve its intended business objectives.
Concentration of Risk
Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. The Company maintains a substantial portion of its cash and cash equivalents and short-term investments in money market funds, commercial paper, corporate debt securities, and asset backed securities. Management believes that the financial institutions that hold its cash, cash equivalents, and short-term
6


investments are financially sound and, accordingly, represent minimal credit risk. Deposits held with banks may exceed the amount of federal insurance limits provided on such deposits.
As of March 31, 2023 and December 31, 2022, two customers each accounted for more than 10% of accounts receivable.
Customers with revenue equal to or greater than 10% of total revenue for the periods indicated were as follows:
Three Months Ended
March 31,
20232022
Customer A58 %30 %
Customer B21 % %
Customer C11 %20 %
Customer D %27 %
Use of Estimates
The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, inventory valuation and reserves, warranty reserves, valuation allowance for deferred tax assets, valuation of earnout and warrant liabilities, stock-based compensation, useful lives of property, plant and equipment, income tax uncertainties, and other loss contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates, and such differences could be material to the Company’s condensed consolidated financial condition and results of operations.
Product Warranties
The Company typically provides a one-year warranty on its products. Estimated future warranty costs are accrued and charged to cost of goods sold in the period that the related revenue is recognized. These estimates are derived from historical data and trends of product reliability and costs of repairing and replacing defective products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. Through March 31, 2023, there were immaterial changes to the accrued warranty liability which was recorded in accrued expenses and other current liabilities on the condensed consolidated balance sheet.
Reclassifications

Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications.

The condensed consolidated statements of convertible preferred stock and stockholders’ equity (deficit) included in this Report for the three months ended March 31, 2022 differ from our previously filed Quarterly Report on Form 10-Q for the three months ended March 31, 2022 by reflecting the immaterial error correction for the misclassification of $1.6 million from prepaid expenses and other current assets to additional paid-in capital for the Lincoln Park Capital Fund, LLC (“Lincoln Park” or “LPC”) commitment fee obligation as of March 31, 2022. The Company corrected the error in the condensed consolidated financial statements for the nine months ended September 30, 2022. The Company believes the correction of the error is immaterial to the previously issued condensed consolidated financial statements for prior periods.
Recently Adopted Accounting Pronouncements
In June 2016, the Financial Standards Accounting Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which significantly changes the way entities recognize credit losses and impairment of financial assets recorded at amortized cost. Currently, the credit loss and impairment model for loans and leases is based on incurred losses, and investments are recognized as impaired when there is no longer an assumption that future cash flows will be collected in full under the originally contracted terms. Under the new current expected credit loss (“CECL”) model, the standard requires immediate recognition of estimated credit losses expected to occur over the remaining life of the asset. As the
7


Company is an emerging growth company, the standard will be effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted. The Company adopted this standard on January 1, 2023 utilizing the modified retrospective method, and the adoption did not have a material impact on its condensed consolidated financial statements.
Recently Issued Accounting Pronouncements
In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments and convertible preferred stock. This update also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The update also requires entities to provide expanded disclosures about the terms and features of convertible instruments, how the instruments have been reported in the entity’s financial statements, and information about events, conditions, and circumstances that can affect how to assess the amount or timing of an entity’s future cash flows related to those instruments. The guidance is effective for interim and annual periods beginning after December 15, 2023 for smaller reporting companies. The Company is currently evaluating the potential impact on its condensed consolidated financial statements and related disclosures from the adoption of this standard.
Note 2. Business Combination
On February 10, 2022, the Business Combination was consummated and the following disclosure has been retained from our previously filed Form 10-K for the comparative prior period in 2022.
The Business Combination was accounted for as a reverse recapitalization as Legacy Cepton was determined to be the accounting acquirer under FASB ASC Topic 805, Business Combinations (ASC 805). The determination is primarily based on the evaluation of the following facts and circumstances:
the equity holders of Legacy Cepton hold the majority of voting rights in the Company;
the board of directors of Legacy Cepton represent a majority of the members of the board of directors of the Company or were appointed by Legacy Cepton;
the senior management of Legacy Cepton became the senior management of the Company; and
the operations of Legacy Cepton comprise the ongoing operations of the Company.
In connection with the Business Combination, outstanding capital stock of Legacy Cepton was converted into common stock of Legacy Cepton and then subsequently converted into Class A common stock of the Company, representing a recapitalization, and the net assets of the Company were acquired at historical cost, with no goodwill or intangible assets recorded. Legacy Cepton was deemed to be the predecessor of the Company, and the consolidated assets and liabilities and results of operations prior to the Closing Date are those of Legacy Cepton. The shares and corresponding capital amounts prior to the Business Combination, have been retroactively restated as shares reflecting the Exchange Ratio (defined below). Operations prior to the Business Combination were those of Legacy Cepton in future reports of the combined entity.
Recapitalization
In connection with the Business Combination, the following occurred to recapitalize the Company:
Shares of Legacy Cepton convertible preferred stock and Class F stock issued and outstanding, were converted into common stock of Legacy Cepton, and thereafter, all shares of Legacy Cepton common stock were subsequently converted into the Company’s Class A common stock, par value $0.0001 per share, at a rate of approximately 2.449 (the “Exchange Ratio”);
Vested stock options to purchase or receive shares of Legacy Cepton common stock (see Note 12) converted into options to purchase or receive shares of the Company’s Class A common stock, par value $0.0001 per share, in accordance with the Exchange Ratio;
8


Outstanding warrants, whether vested or unvested, to purchase shares of Legacy Cepton common stock (see Note 14) converted into shares of the Company’s Class A common stock, par value $0.0001 per share, in accordance with the Exchange Ratio;
Outstanding unvested stock options to purchase or receive shares of Legacy Cepton common stock (see Note 12) converted into unvested stock options to purchase or receive shares of the Company’s Class A common stock upon the same terms and conditions that were in effect with respect to such stock options immediately prior to the Business Combination, after giving effect to the Exchange Ratio;
The Company’s certificate of incorporation was amended and restated to, among other things, increase the total number of authorized shares of capital stock to 355,000,000 shares, of which 350,000,000 shares were designated common stock, $0.00001 par value per share, and of which 5,000,000 shares were designated preferred stock, $0.00001 par value per share and to reclassify each share of Class A common stock and Class B common stock into one share of common stock.
PIPE Investment
Contemporaneously with the execution of the Merger Agreement, GCAC entered into subscription agreements with certain investors (the “PIPE Investors”), pursuant to which the PIPE Investors agreed to purchase an aggregate of 5,950,000 shares of common stock at a purchase price of $10.00 per share, or an aggregate purchase price of $59.5 million (the “PIPE Investment”).
Redemption
Prior to the closing of the Business Combination on February 10, 2022, certain GCAC public shareholders exercised their right to redeem certain of their outstanding shares for cash, resulting in the redemption of 15,589,540 shares of GCAC Class A common stock for an aggregate payment of $155.9 million.
Public and Private Placement Warrants
GCAC warrants issued in connection with the IPO (“Public Warrants”) and in connection with the private placement units held by the Sponsor (“Private Placement Warrants”) remained outstanding after the closing of the Business Combination. The warrants became exercisable to purchase shares of the Company’s common stock at an exercise price of $11.50 per share 30 days after the completion of the Business Combination, subject to other conditions, including with respect to the effectiveness of a registration statement covering the shares of common stock underlying such warrants, and will expire five years after the completion of the Business Combination or earlier upon redemption or liquidation. The Public Warrants are equity-classified and were valued based on the instruments’ publicly listed trading price as of the Closing Date. The Private Placement Warrants are liability-classified and are valued on a recurring basis with changes in fair value recognized as a gain or loss upon remeasurement (see Note 14).
Transaction Costs
For the three months ended March 31, 2022, the Company incurred direct and incremental costs of approximately $31.7 million in connection with the Business Combination and the related equity issuance, consisting primarily of investment banking, legal, accounting, and other professional fees, which were recorded to additional paid-in capital as a reduction of proceeds. An approximate additional $2.6 million of transaction costs were recorded in general and administrative expense related to the liability classified instruments assumed subsequent to the Business Combination.
Transaction Proceeds
Upon closing of the Business Combination, the Company received gross proceeds of $76.1 million from the Business Combination and PIPE Investment, offset by total transaction costs of $40.7 million.
9


Note 3. Revenue
The Company disaggregates its revenue from contracts with customers by country of domicile based on the shipping location of the customer. Total revenue disaggregated by country of domicile is as follows (dollars in thousands):
Three Months Ended March 31,
20232022
Revenue% of RevenueRevenue% of Revenue
Revenue by country of domicile:
Japan$1,036 70 %$801 54 %
United States115 8 %613 41 %
China317 21 %  %
Other17 1 %71 5 %
Total$1,485 100 %$1,485 100 %

As of March 31, 2023 and December 31, 2022, the Company had $0.4 million and $0.5 million of contract liabilities included in accrued expenses and other current liabilities, respectively, and no contract assets.
Note 4. Fair Value Measurement
The following tables summarize the Company's assets and liabilities measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands):
March 31, 2023
Level 1Level 2Level 3Total
Assets:
Cash equivalents:
Money market fund$8 $ $ $8 
Total cash equivalents$8 $ $ $8 
Short-term investments:
Commercial paper$ $22,377 $ $22,377 
U.S. treasury securities 2,951  2,951 
U.S. government agency securities 9,772  9,772 
Corporate debt securities 2,966  2,966 
Total short-term investments$ $38,066 $ $38,066 
Total assets measured at fair value$8 $38,066 $ $38,074 
Liabilities:
Warrant liability$ $347 $ $347 
Earnout liability  158 158 
Total liabilities measured at fair value$ $347 $158 $505 
10


December 31, 2022
Level 1Level 2Level 3Total
Assets:
Cash equivalents:
Money market fund$10,437 $ $ $10,437 
Total cash equivalents$10,437 $ $ $10,437 
Short-term investments:
U.S. government agency securities$ $2,493 $ $2,493 
Corporate debt securities 1,210  1,210 
Total short-term investments$ $3,703 $ $3,703 
Total assets measured at fair value$10,437 $3,703 $ $14,140 
Liabilities:
Warrant liability$ $440 $ $440 
Earnout liability  920 920 
Total liabilities measured at fair value$ $440 $920 $1,360 
Cash equivalents consist primarily of money market funds with original maturities of three months or less at the time of purchase, and the carrying amount is a reasonable estimate of fair value. Short-term investments consist of investment securities with original maturities greater than three months but less than twelve months and are included as current assets in the condensed consolidated balance sheets. For short-term investments, the fair value as of March 31, 2023 and December 31, 2022 approximates amortized cost basis.
Because the transfer of Private Placement Warrants to non-permitted transferees would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is consistent with that of a Public Warrant. Accordingly, the Private Placement Warrants are classified as Level 2 financial instruments under warrant liability.
The value of the earnout liability is classified as Level 3 under the fair value hierarchy because it has been valued based on significant inputs not observable in the market.
Changes in Level 3 liabilities related to earnout liability measured at fair value for three months ended March 31, 2023 (in thousands):
Three Months Ended March 31, 2023
Balance as of December 31, 2022$920 
Gain on change in fair value of earnout liability(762)
Balance as of March 31, 2023$158 

The gain on change in the fair value of the earnout liability was shown in the condensed consolidated statement of operations and comprehensive income (loss).
Note 5. Inventories
Inventories consist of the following as of March 31, 2023 and December 31, 2022 (in thousands):
March 31,
2023
December 31,
2022
Raw materials$1,529 $1,179 
Work-in-process1,004 1,141 
Finished goods897 665 
Total inventories$3,430 $2,985 
11


Inventories are carried and depicted above at the lower of cost or net realizable value. Write-downs were immaterial for the three months ended March 31, 2023 and 2022.
Note 6. Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following as of March 31, 2023 and December 31, 2022 (in thousands):
March 31,
2023
December 31,
2022
Prepaid insurance$2,732 $2,533 
Other prepaid expenses1,440 1,376 
Deferred transaction costs 993 
Payroll tax receivable120 865 
Other current assets480 505 
Total prepaid expenses and other current assets$4,772 $6,272 
Note 7. Property and Equipment, Net
Property and equipment, net, consists of the following as of March 31, 2023 and December 31, 2022 (in thousands):
March 31,
2023
December 31,
2022
Machinery and equipment$2,094 $1,445 
Automobiles101 101 
Leasehold improvements189 189 
Computer and equipment116 116 
Total property and equipment2,500 1,851 
Less: accumulated depreciation and amortization(979)(869)
Total property and equipment, net$1,521 $982 
Depreciation and amortization related to property and equipment was immaterial for the three months ended March 31, 2023 and 2022.
Note 8. Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following as of March 31, 2023 and December 31, 2022 (in thousands):
March 31,
2023
December 31,
2022
Accrued payroll$1,763 $1,300 
Accrued expenses and taxes563 375 
Deferred revenue355 525 
Warranty reserve85 65 
Total accrued expenses and other current liabilities$2,766 $2,265 
Note 9. Debt
Trinity Loan Agreement
On January 4, 2022, Legacy Cepton entered into a loan and security agreement and subsequent amendments (“Trinity Loan Agreement”) with Trinity Capital Inc. (“Trinity”) to borrow up to $25.0 million through January 1, 2023 at a floating per annum rate equal to the greater of (i) 10.75% or (ii) the prime rate plus 7.0%. The loan had a maturity date of February 1,
12


2026. In connection with the Trinity Loan Agreement, Legacy Cepton issued a warrant to purchase 96,998 shares of common stock with an exercise price of $16.89 per share (see Note 14). The fair value of the warrant was estimated to be $1.3 million on the date of issuance. On January 4, 2022, Legacy Cepton borrowed $10.0 million under the agreement, incurring $0.3 million in transaction costs which were accounted for as a debt discount. Legacy Cepton also recognized a pro rata portion of the warrant fair value as a debt discount related to the $10.0 million loan. Amortization of debt discounts, in accordance with the effective interest method, are recorded as interest expense in the accompanying condensed consolidated statement of operations and comprehensive income (loss) during 2022. Obligations under the Trinity Loan Agreement were secured by interests in substantially all of the Company’s assets. The agreement contained customary affirmative and negative covenants.
On November 7, 2022, the Company repaid all outstanding principal and accrued interest under and terminated the Trinity Loan Agreement including a 1.5% prepayment penalty and 2.5% end of term payment.
Secured Term Loan Agreement with Koito

On October 27, 2022, the Company entered into an Investment Agreement (the “Investment Agreement”) with Koito Manufacturing Co., Ltd. (“Koito”) (See Note 10). Concurrently with the execution of the Investment Agreement, the Company entered into a Secured Term Loan Agreement with Koito to borrow Japanese Yen ¥5.8 billion (approximately $39.4 million) (the “Secured Term Loan Agreement”). The loan accrued interest at a rate equal to 1.0% per annum and was payable at maturity. The Secured Term Loan Agreement entered into with Koito was a related party transaction issued at a below market interest rate. To reflect what a similar debt instrument would be issued at with a market interest rate, the Company recorded a $2.0 million debt discount accounted for as a capital contribution within additional paid-in capital in the condensed consolidated balance sheet as of December 31, 2022. Amortization of the debt discount, in accordance with the effective interest method, was recorded as interest expense in the accompanying condensed consolidated statement of operations and comprehensive income (loss). The loan was set to mature on the earlier of three business days after the closing of the transactions contemplated by the Investment Agreement and the date on which the Investment Agreement is terminated in accordance with its terms. On November 7, 2022, the Company borrowed Japanese Yen ¥5.8 billion (approximately $39.4 million) under the Secured Term Loan Agreement. Obligations under the Secured Term Loan Agreement were secured by interests in substantially all of the Company’s assets, including all patents. The agreement contained customary affirmative and negative covenants. On January 24, 2023, the Company repaid all outstanding principal and accrued interest under the Secured Term Loan Agreement.
During the three months ended March 31, 2023, the Company recognized $0.3 million in interest expense in connection with the borrowings under the Secured Term Loan Agreement. Additionally, the Company recognized a $0.8 million foreign currency transaction loss on repayment using the applicable exchange rate on January 24, 2023 and a $1.1 million loss on extinguishment of debt.
Note 10. Convertible Preferred Stock
Convertible Preferred Stock Prior to Business Combination
As discussed in Note 2, the Company has retroactively adjusted the shares issued and outstanding prior to February 10, 2022 to give effect to the Exchange Ratio to determine the number of shares of common stock into which they were converted.
Prior to the Business Combination, Legacy Cepton had shares of $0.00001 par value Series A, Series B, Series B-1, and Series C preferred stock outstanding, all of which were convertible into shares of common stock of Legacy Cepton on a 1:1 basis, subject to certain anti-dilution protections.
13


The authorized, issued, and outstanding shares of Convertible Preferred Stock, and liquidation preferences prior to February 10, 2022 were as follows:
Issuance DateShares
Authorized
Shares Issued and
Outstanding
Original Issue
Price per Share
Aggregate
Liquidation
Preference
Series AJuly 6, 20168,000,000 8,000,000 $1.0000 $8,000,000 
Series BJuly 13, 20184,069,600 4,069,600 $6.2500 25,435,000 
Series B-1July 13, 20183,272,475 3,272,475 $3.1250 10,226,484 
Series CFebruary 4, 20207,463,934 6,329,416 $8.3736 52,999,998 
22,806,009 21,671,491  $96,661,482 
Upon the closing of the Business Combination, the 21,671,491 shares of convertible preferred stock issued and outstanding were converted into 53,078,571 shares of common stock at the Exchange Ratio.
Convertible Preferred Stock with Koito
On October 27, 2022, the Company entered into the Investment Agreement with Koito pursuant to which, among other things, at the closing of the transactions, and based on the terms and subject to the conditions set forth therein, the Company issued and sold to Koito, 100,000 shares of Series A Convertible Preferred Stock, par value $0.00001 per share (the “Preferred Stock”), for a purchase price of $100.0 million (the “Initial Liquidation Preference”). The issuance and sale of the Preferred Stock and related matters were approved by the Company’s stockholders on January 11, 2023, and the Preferred Stock issued to Koito on January 19, 2023 (the “Closing Date”). In connection with the issuance of the Preferred Stock, the Company incurred direct and incremental expenses of $1.1 million, comprised of transaction fees, and financial advisory and legal expenses, which reduced the carrying value of the Preferred Stock.
As of March 31, 2023, the Company had authorized 5,000,000 shares of preferred stock, each with a par value of $0.00001. As of March 31, 2023, there were 100,000 shares of preferred stock issued and outstanding.
Dividend Provisions
The Preferred Stock ranks senior to the Company’s common stock with respect to payment of dividends and rights on the distribution of assets on any liquidation, dissolution or winding up of the affairs of the Company and ranks junior to all secured and unsecured indebtedness. The Preferred Stock has an Initial Liquidation Preference of $100.0 million, representing an aggregate Liquidation Preference (as defined below) of $100.0 million upon issuance. At the Company’s election, the Preferred Stock carries a 4.250% per annum dividend if paid in kind or a 3.250% per annum dividend if paid in cash, in each case payable quarterly in arrears. Holders of the Preferred Stock are entitled to the dividend regardless of whether declared by the Company’s board of directors. Such dividends shall accrue and compound quarterly in arrears from the date of issuance of the shares. The Preferred Stock is also entitled to fully participate in any dividends paid to the holders of common stock in cash, in stock or otherwise, on an as-converted basis.
Liquidation Rights
In the event of any Liquidation, holders of the Preferred Stock are entitled to receive an amount per share equal to the greater of (1) the Initial Liquidation Preference per share plus any accrued or declared but unpaid dividends on such shares (the “Liquidation Preference”) or (2) the amount payable if the Preferred Stock were converted into common stock. The Preferred Stock will have distribution and liquidation rights senior to all other equity interests of the Company. As of March 31, 2023, the Liquidation Preference of the Preferred Stock was $100.8 million.
Conversion Feature
The Preferred Stock may be converted, at any time in whole or in part at the option of the holder, beginning on January 19, 2024, into shares of the Company’s common stock equal to the quotient obtained by dividing the sum of the Liquidation Preference by the conversion price of $2.585 (the “Conversion Price”).


14


Anti-Dilution Provisions
The Conversion Price of the Preferred Stock has customary anti-dilution provisions for stock splits, stock dividends, sales of shares through a tender or exchange offer, including under the Purchase Agreement with Lincoln Park, subject to customary exceptions for issuances pursuant to current or future equity-based incentive plans or arrangements (including upon the exercise of employee stock options).
Optional Redemption
The Company has the option, upon 30 days’ advance notice, to (A) repurchase all (but not less than all) of the outstanding Preferred Stock held by Koito or a Permitted Transferee (as defined in the Investment Agreement) on or after the second anniversary of the closing occurring after the end of the applicable fiscal year for which the Company has recorded positive net income, if the Company has recorded positive net income pursuant to GAAP in its audited financial statements for any fiscal year the end date of which falls after the fifth anniversary of the closing and (B) all or any portion of the outstanding Preferred Stock not held by Koito or a Permitted transferee any time after the seventh anniversary of the closing.
Fundamental Change Put Right
Upon occurrence of a fundamental change event, each holder of outstanding shares of the Preferred Stock has the right to require the Company to repurchase any or all of their Preferred Stock at a purchase price per share equal to the Liquidation Preference or in lieu of a repurchase, elect to convert the Preferred Stock into the Company’s common stock equal to the quotient obtained by dividing 110% of the Liquidation Preference by the Conversion Price.
A fundamental change is defined as either the direct or indirect sale, or other disposition of all or substantially all assets of the Company and its subsidiaries to any third party or the consummation of any transaction, the result of which is that any third party or group of third parties become the beneficial owner of more than 50% of the voting power of the Company. Solely with respect to shares held by Koito, the definition of a fundamental change is expanded to include agreements entered by the Company to issue equity exceeding 10% of the Company’s common stock, or any strategic alliance partnership, or joint venture agreement to a third party deemed to be a competitor with Koito (subject to certain exceptions).
Note 11. Stockholders’ Equity (Deficit)
Common Stock
Holders of common stock were entitled to one vote per share, and to receive dividends when, as and if declared by the board of directors, and, upon liquidation or dissolution, were entitled to receive all assets available for distribution to stockholders. The holders had no preemptive or other subscription rights and there were no redemption or sinking fund provisions with respect to such shares.
Upon the closing of the Business Combination, the 27,618,907 shares of Legacy Cepton common stock issued and outstanding were converted into 67,645,189 shares of common stock at the Exchange Ratio.
As of March 31, 2023, the Company had authorized 350,000,000 shares of common stock, each with a par value of $0.00001. As of March 31, 2023, there were 156,844,093 shares of common stock issued and outstanding.
Lincoln Park Transaction
On November 24, 2021, Legacy Cepton entered into a Purchase Agreement with Lincoln Park, pursuant to which Lincoln Park has agreed to purchase up to $100.0 million of common stock (subject to certain limitations contained in the Purchase Agreement) from time to time over a 36-month period (the “Purchase Agreement”) after the consummation of the Business Combination and certain other conditions set forth in the Purchase Agreement. The Company may, from time to time and at its sole discretion, direct Lincoln Park to purchase common stock in accordance with daily dollar thresholds as determined within the Purchase Agreement. The purchase price per share for common stock will be the lower of: (i) the lowest trading price for shares of common stock on the market in which it is listed, on the applicable purchase date and (ii) the average of the three (3) lowest closing sale price for common stock during the ten (10) consecutive business days ending on the business day immediately preceding such purchase date. In consideration for entering into the Purchase Agreement, the Company issued, as a commitment fee, 50,000 shares of common stock to Lincoln Park on the date of the closing of the Business Combination and subsequently an additional 150,000 shares of common stock 180 days after the date of the closing of the Business Combination.
15


As of March 31, 2023, 1,142,505 shares of common stock had been sold in aggregate to Lincoln Park under the Purchase Agreement for consideration of $1.7 million.
Class F Stock
Holders of Legacy Cepton’s Class F stock were entitled to the same voting rights as the equivalent number of common stock on an as-converted basis, and to receive dividends when, as and if declared by the board of directors. The holders had conversion rights for conversion into shares of common stock and preferred stock. The holders were subject to vesting terms wherein each holder acquired a vested interest in the stock over a service period of four years.
Upon the closing of the Business Combination, the 8,372,143 shares of Legacy Cepton Class F stock issued and outstanding were converted into 8,372,143 shares of common stock of Legacy Cepton and then subsequently converted into 20,505,344 shares of common stock of the Company at the Exchange Ratio.
Note 12. Stock-Based Compensation
Equity Incentive Plans
On July 5, 2016, Legacy Cepton adopted the 2016 Stock Plan (the “2016 Plan”) under which 4,800,000 shares of Legacy Cepton’s common stock were reserved for issuance to employees, nonemployee directors, consultants, and advisors. As a result of the Business Combination, the Company no longer grants new incentive awards under the 2016 Plan and there were no shares reserved or available for future issuance under the 2016 Plan. Incentive awards existing under the 2016 Plan immediately prior to the Business Combination were converted into options to receive shares of common stock through application of the Exchange Ratio (“Post Conversion Awards”).
On February 10, 2022, the Company adopted the 2022 Stock Plan (the “2022 Plan”) under which 15,123,142 shares of the Company’s common stock were reserved for issuance to employees, nonemployee directors, consultants, and advisors. Per the terms of the 2022 Plan, in the event any Post Conversion Awards issued and outstanding under the 2016 Plan are cancelled, terminated, or expire, said number of shares will be made available for issuance under the 2022 Plan. The share limit shall automatically increase on the first trading day in January of every calendar year during the term of the 2022 Plan, by an amount equal to the lesser of (i) two percent (2%) of the total number of shares of common stock issued and outstanding on December 31 of the immediately preceding calendar year or (ii) such number of shares of common stock as may be established by the board of directors. As of March 31, 2023, there were 10,086,988 shares of common stock reserved for issuance under the 2022 Plan.
Incentive Stock Options and Nonqualified Stock Options
A summary of the Company’s employee and nonemployee stock option activity for the three months ended March 31, 2023 is presented below:
Shares Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contract
Term
(in years)
Aggregate
Intrinsic
Value
(in thousands)
Outstanding as of December 31, 202214,261,984 $2.14 6.5$6,486 
Granted $ 
Exercised(82,923)$0.10 
Expired/Forfeited(267,889)$3.39 
Outstanding as of March 31, 2023
13,911,172 $2.13 6.3$1,371 
Exercisable as of March 31, 2023
10,593,841 $1.54 5.7$1,371 
Vested and expected to vest as of March 31, 2023
13,911,172 $2.13 6.3$1,371 
As of March 31, 2023, there was $7.5 million of unrecognized stock-based compensation expense related to unvested stock options expected to be recognized over a weighted-average period of 1.8 years. The total intrinsic value of options exercised during the three months ended March 31, 2023 was $0.1 million. The Company recognizes forfeitures as they occur.
16


Restricted Stock Units
The Company granted restricted stock units (“RSUs”) under the 2022 Plan in the second quarter of 2022. Each RSU granted under the 2022 Plan represents a right to receive one share of the Company’s common stock when the RSU vests. RSUs generally vest over a period of one to four years based on fulfilling a service condition. The fair value of RSU is equal to the fair value of the Company’s common stock on the date of grant.
A summary of the Company’s RSU activity for the three months ended March 31, 2023 is presented below:
SharesWeighted Grant Date Fair Value
Outstanding as of December 31, 20224,708,692 $2.57 
Granted3,835,166 $1.18 
Released(13,462)$1.18 
Forfeited(122,511)$1.72 
Outstanding as of March 31, 20238,407,885 $1.95 
As of March 31, 2023, there was $12.4 million of unrecognized stock-based compensation expense related to unvested RSUs expected to be recognized over a weighted-average period of 2.5 years. The total intrinsic value of RSUs outstanding at March 31, 2023 was $3.9 million. The Company recognizes forfeitures as they occur.
Performance-based Stock units
During the year ended December 31, 2022, the Company granted 123,000 shares of performance-based stock units (“PSUs”) under the 2022 Plan, with 66,000 shares in the first tranche and 57,000 shares in the second tranche. Each grant to consist of two market-based vesting tranches, with the first tranche to vest if, at the close of regular trading for 20 trading days out of any period of 30 consecutive trading days, either (i) the closing price of the Company’s common stock exceeds $15.00 per share or (ii) the Company’s market capitalization exceeds $2.1 billion; and the second tranche to vest if, at the close of regular trading for 20 trading days out of any period of 30 consecutive trading days, either (i) the closing price of the Company's common stock exceeds $17.50 per share or (ii) the Company’s market capitalization exceeds $2.5 billion, provided in each case that the applicable stock price or market capitalization goal must be achieved no later than February 10, 2025 for the applicable tranche to vest, and provided further that the vesting of each tranche is subject to the grantee’s continued employment with the Company through the day on which the applicable goal is achieved.
The fair value of the PSUs at valuation date was determined using a Monte Carlo valuation model that utilizes significant assumptions, including expected volatility, dividend yield, stock price as of the valuation date, market capitalization targets and the corresponding share price targets necessary for each tranche of PSUs to vest, expected life, and risk-free rate.
The fair value of the PSUs at valuation date was $0.1 million with weighted average grant date fair value of $0.98, amortizing over a derived service period of 21 and 22 months for each tranche, respectively.
Stock-Based Compensation
For the three months ended March 31, 2023 and 2022, the Company recorded stock-based compensation expense as follows (in thousands):
Three Months Ended
March 31,
20232022
Cost of revenue$60 $43 
Research and development expense1,177 829 
Selling, general and administrative expense1,052 475 
Total stock-based compensation expense$2,289 $1,347 
17


For the three months ended March 31, 2023 and 2022, the Company capitalized $51 thousand and $43 thousand, respectively, of stock-based compensation expense into inventory. There were no modifications during the three months ended March 31, 2023 and 2022.
Note 13. Earnout Liability
In addition to the shares issued upon closing of the Business Combination (see Note 2), additional contingent shares (“Earnout Shares”) are payable to each holder of common stock and/or options receiving consideration in the Business Combination, in the amounts set forth below:
(a)
If the closing price of the Company’s common stock equals or exceeds $15.00 per share for any 20 trading days within any consecutive 30-trading day period that occurs after the Closing Date and on or prior to the three-year anniversary of the Closing Date, then, the Company will issue to each holder of common stock that is entitled to Earnout Shares a number of shares of common stock equal to such holder’s pro rata portion of 7,000,000 shares.
(b)
If the closing price of the Company’s common stock equals or exceeds $17.50 per share for any